Discontinued — last reported Q4 '21

Share Repurchase Program - Amount Utilized

Equity

Eli Lilly Share Repurchase Program - Amount Utilized decreased by 5.4% to $12.40B in Q3 2025 compared to the prior quarter. Year-over-year, this metric grew by 526.3%, from $1.98B to $12.40B.

Analysis

StatementBalance Sheet Statement
SectionEquity
First reportedQ2 2016
Last reportedQ4 2021
Metric ID: share_repurchase_program_amount_utilized

Historical Data

14 periods
 Q2 '21Q3 '21Q1 '22Q2 '22Q3 '22Q1 '23Q2 '23Q3 '23Q1 '24Q2 '24Q3 '24Q1 '25Q2 '25Q3 '25
Value$500.00M$500.00M$3.25B$3.25B$3.25B$2.50B$2.50B$2.50B$2.50B$2.50B$1.98B$13.80B$13.11B$12.40B
QoQ Change—+0.0%+550.0%+0.0%+0.0%-23.1%+0.0%+0.0%+0.0%+0.0%-20.8%+597.0%-5.0%-5.4%
YoY Change———+550.0%+550.0%-23.1%-23.1%-23.1%+0.0%+0.0%-20.8%+452.0%+424.4%+526.3%
Range$500.00M – $13.80B
CAGR+168.6%
Avg YoY Growth+219.3%
Median YoY Growth+0.0%
Current Streak2 quarters decline

Frequently Asked Questions

What is Eli Lilly's share repurchase program - amount utilized?
Eli Lilly (LLY) reported share repurchase program - amount utilized of $12.40B in Q3 2025.
How has Eli Lilly's share repurchase program - amount utilized changed year-over-year?
Eli Lilly's share repurchase program - amount utilized increased by 526.3% year-over-year, from $1.98B to $12.40B.

Cookie Preferences

We use cookies for analytics. See our Privacy and Cookie Policy.